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Context: Hypospadias is a common congenital malformation of the male external genitalia with
a multifactorial etiology. Little is known about the genes involved in hypospadias. A few genetic
associations have been reported but mainly in studies of small sample size. Most of these associ-
ations have not been replicated.
Objective: The aim of this study was to investigate whether previously reported associations for
four single-nucleotide polymorphisms (SNPs) in genes involved in hormonal pathways could be
replicated in a large Dutch hypospadias sample. The SNPs investigated are rs523349 in steroid-5-
reductase (SRD5A2), rs6932902 in estrogen receptor 1 (ESR1), rs2987983 in ESR2, and rs11119982
in activating transcription factor 3 (ATF3).
Design, Participants, and Methods: We genotyped 620 Caucasian hypospadias cases and 596
controls for these SNPs using TaqMan-based genotyping.
Results:We did not replicate the associations of the SNPs in SRD5A2 and ESR1 with hypospadias.
The SNPs in ESR2 and ATF3 were borderline associated with hypospadias [odds ratios 0.9 (95%
confidence interval 0.7–1.0) and 1.2 (95% confidence interval 1.0–1.4), respectively] but in the
opposite direction compared with earlier publications. Stratification according to localization of
the urethral opening produced comparable results in the subgroups.
Conclusions: The lack of consistency between our and previously performed studies might repre-
sent spurious results or chance findings in our or the earlier studies, differences in criteria used to
select the study populations, or a real difference between populations, i.e. different genes con-
tributing to disease risk. These results once again confirm the importance of replication in genetic
association approaches. (J Clin Endocrinol Metab 95: 2384–2390, 2010)
Hypospadias, a hypoplasia of the penis with proximaldisplacement of the urethral meatus on the ventral
aspect of the penis, results from developmental arrest of
the urethral fusion. The appearance of hypospadias is di-
verse, with the opening being located glanular, penile,
scrotal, or even in the perineal region in different individ-
uals. Although hypospadias is a common congenital dis-
order affecting approximately 21 in 10000 live births in
The Netherlands in 2006 (1), its etiology is incompletely
understood. The development of the male external geni-
talia is a complex process influenced bymultiple genes (2),
of which those coding for sex hormones have been the
focus of interest in most previous studies. Originally stud-
ies trying to elucidate the etiology of hypospadias mainly
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focused on male hormones, but more recently focus has
broadened to include female hormones as well. Estrogen
receptors are expressed in the human fetal male external
genitalia (3), and exposure to estrogens seems to increase
the risk of hypospadias (4, 5). Furthermore, estrogen-re-
sponsive genes are up-regulated in hypospadias (6, 7).
Hypospadias clusterswithin families; 7%ofhypospadias
cases have a first-, second-, or third-degree relative with hy-
pospadias,whereas theexpectedrateof familial casesamong
the general population is 3%(8).This familial aggregation is
believed to be caused by genetic rather than intrauterine en-
vironmental factors (9). Rare mutations in genes have been
found in only a fewhypospadias patients, for example in the
genesencodingtheandrogenreceptor (AR) (10–13), steroid-
5-reductase (SRD5A2) (14), hydroxy--5-steroiddehydro-
genase (HSD3B2) (15),mastermind-like domain containing
1 [MALMD1, previously named chromosomeXopen read-
ing frame 6 (CXorf6)] (16), and bone morphogenetic pro-
teins 4 and 7 (BMP4 andBMP7) (17) as well as in the genes
coding for homeobox A4 and B6 (HOXA4 and HOXB6)
(17). However, most investigators are convinced that single
mutations are not likely to be the cause of the majority of
nonsyndromal hypospadias cases (10–13, 15, 18). Segrega-
tion analysis suggests that the majority of cases have a mul-
tifactorial etiology (19).
According to the common gene, common disorder hy-
pothesis (20), multiple frequently occurring genetic vari-
ants (polymorphisms), each with a relatively small effect,
contribute tomultifactorial disorders. Althoughnotmany
studies investigated polymorphisms in relation to hypos-
padias, some associations with hypospadias have been re-
ported, mainly of polymorphisms in endocrine-related
genes, namely inAR (21, 22), SRD5A2 (23, 24), the genes
encoding estrogen receptors 1 (ESR1) (25, 26) and 2
(ESR2) (26–28), and activating transcription factor 3
(ATF3) (29). Furthermore, polymorphisms in the genes
encoding fibroblast growth factor 8 (FGF8) (18) and FGF
receptor 2 (FGFR2) (18) have been associated with hypo-
spadias. Overall, however, the numbers of samples ana-
lyzed in these studies were relatively small, with only 43–
380 cases plus controls included. Only three of the above
associations (rs523349 in SRD5A2, the GGN repeat in
AR, and the CA repeat in ESR2) have been reported in
more thanone study.Replication of results is amajor issue
in research into genetic causes of multifactorial disorders
because first studiesoftenappear tooverestimate the effect
of the genetic variant (so-called winner’s curse) (30), and
studies reporting positive results aremore likely to be pub-
lished than those reporting negative results (publication
bias) (31). Therefore, the aim of this study was to inves-
tigate whether the previously reported associations of sin-
gle-nucleotide polymorphisms (SNPs) in genes involved in
hormonal pathways could be replicated in a large Dutch
sample of 620 hypospadias cases and 596 controls.
SNPs in four genes were studied; SRD5A2, ESR1,
ESR2, and ATF3. SRD5A2 encodes an enzyme that con-
verts circulating testosterone in the genital tubercle to the
more potent androgen dihydrotestosterone, which stim-
ulates normal differentiation and development of the gen-
ital tubercle into the external genitalia (2). ESR1 and
ESR2 encode estrogen receptors, andATF3 is an estrogen-
responsive gene, showing strong up-regulation in hypos-
padias (6, 7). Furthermore, we investigated whether lo-
calization of the meatus influenced our findings because
hypospadias with different localizations of the urethral
opening arise at distinct embryologic stages with different
genes likely to be involved in the process.
Subjects and Methods
Cases and controls
The Aetiologic Research into Genetic and Occupational/Envi-
ronmental Risk Factors for Anomalies in Children (AGORA)
project of the Radboud University Nijmegen Medical Centre
aims at building a data bank and biobank with questionnaire
data and DNA samples from patients with a congenital disorder
and their parents. For the current study, DNA collected prospec-
tively and retrospectively was available from 679 hypospadias
cases. The majority of the cases were of European Caucasian
descent (92%), whereas descent was not Caucasian (5%) or un-
known (3%) for the remaining cases.OnlyCaucasian caseswere
included in the analyses. The retrospectively collected cases (n
478) have been described before in studies on environmental risk
factors for hypospadias (32, 33). Routine data collection since
2005 provided the prospective cases.Medical records of all cases
were reviewed to identify syndromal cases of hypospadias and
clinical characteristics of patients and determine the anatomical
locationof the urethral opening.The locationwasdeterminedby
experiencedpediatricurologistsduringphysical examinationbe-
fore surgery. For the current study, anatomical locationwas sub-
divided into three categories: anterior hypospadias (glanular and
subcoronal), middle hypospadias (penile), and posterior hypo-
spadias (penoscrotal, scrotal, and perineal).
Controlswereobtained fromtheNijmegenBiomedical Study, a
population-based survey conducted by the Department of Epi-
demiology, Biostatistics, and Health Technology Assessment
and the Department of Clinical Chemistry of the Radboud
University Nijmegen Medical Centre in 2003. Age- and sex-
stratified randomly selected inhabitants of the municipality of
Nijmegen (n 22500) received an invitation to fill out a postal
questionnaire, e.g. on lifestyle and medical history, and to
donate blood samples. The response to the questionnaire was
42% (n  9373), whereas 72% (n  6747) of the responders
also donated blood samples (34). The 596 youngest males of
Dutch descent were selected for the current study. None of
them had reported penile surgery in the self-report question-
naires administered by the Nijmegen Biomedical Study.
The regional Committee on Research Involving Human Sub-
jects approved both studies. All participants gave written in-
formed consent for participation in the study.
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Genotyping
Blood was collected in EDTA containing tubes for the largest
part of the study population (n 980), whereas saliva was col-
lected using Oragene containers (n  295; DNA Genotek Inc.,
Ottawa, Ontario, Canada). DNA was extracted from blood or
saliva using standard methods. Samples were genotyped for
rs523349 in SRD5A2 (23, 24), rs6932902 in ESR1 (25),
rs2987983 in ESR2 (27), and rs11119982 in ATF3 (29) using
5-nuclease TaqMan SNP genotyping assays (SRD5A2:
C_2362601_10, ESR1: C_2823640_10, ESR2: C_1436929_20,
ATF3: C_27262262_10; Applied Biosystems, Foster City, CA).
PCRs were carried out in 96-well plates in a 10-l volume
containing 10 ng genomic DNA, 5 l Taqman universal PCR
master mix, 0.125l assaymix, andmilli-Q. The PCR consisted
of an initial denaturation step at 95 C for 10min followed by 40
cycles of denaturation at 92 C for 15 sec and annealing and
extension at 60 C for 60 sec. After PCR, allele-specific fluores-
cence was measured on an ABI 7500 FAST (Applied Biosys-
tems). In each plate, five wells were loaded with randomly se-
lected duplicate DNA samples from the same and other plates for
quality control purposes. In addition, four blanks were included in
each plate. Genotyping was carried out in a laboratory recognized
and granted accreditation for quality control by the coordinating
committee for improvement of quality control of laboratory re-
search in health care.
Statistical analysis
Statistical analyses were performed using SPSS 16.0 (SPSS,
Chicago, IL). Genotype frequencies in controls were tested for
accordance with Hardy-Weinberg equilibrium. For the four
SNPs, themost frequent homozygous genotypes in controlswere
used as reference values. Odds ratios (OR) for hypospadias risk
and corresponding 95% confidence intervals (CI) were calcu-
lated at genotype and allelic level. Furthermore, 2 tests were
performed. P  0.05 was considered statistically significant in
the primary analyses. Applying the Bonferroni correction for
multiple comparisons decreased the significance threshold to
0.004 for the 12 comparisons made.
In a second step, cases were subdivided into anterior, middle,
and posterior categories, and the statistical analyseswere repeated.
Furthermore, to exclude bias due to the different sources of DNA
(i.e. blood and saliva), the analyses were repeated separately for
cases of whom DNA was obtained from either blood or saliva.
To enable a better comparison between the results of our study
and the previously published results, we recalculated the risk esti-
mates of these studies according to the procedures described above.
Exact 95% CI around the ORs were calculated using the Fisher
exact method, whenever expected cell numbers were below five.
Results
Figure 1 shows a flow chart of the collection and selection
of cases for this study. In the analysis of the complete
sample, 620 cases were included, whereas in the second
stepof the analysis, 579 case samples couldbe included for
whom the hypospadias location had been determined. Ta-
ble 1 shows the clinical characteristics of the patients.
More than half of the posterior cases underwent the onlay
island flap procedure. Other techniques used were the tu-
bular graft (Duckett’s procedure) and tubularized incised
plate urethroplasty. One third of these posterior hypos-
padias cases needed a two-stage repair.
Genotyping of the four SNPs was completed with a suc-
cess rate ofmore than99%.All genotype frequencies in con-
trols were in Hardy Weinberg equilibrium (SRD5A2: P 
0.63; ESR1: P 0.98; ESR2: P 0.22; ATF3: P 0.31).
Table 2presents the results of theprimary genotype and
allele association analyses of the four SNPs. For the SNP
in SRD5A2, therewasno indicationof anassociationwith
hypospadias in our sample, neither at the genotypic nor at
the allelic level. For the SNPs in ESR1 and ATF3, odds
ratio for the risk of hypospadias were statistically signifi-
cantly increased for both variant genotypes (ATF3) and the
variant allele (ESR1, ATF3). For the SNP in ESR2, both
variant genotypes and the variant allele appeared to be neg-
atively associated with hypospadias, although not statisti-
cally significant.Aftercorrectionformultiple testing,noneof
the results remained statistically significant. Separate analyses
fortheanterior,middle,andposteriorcategoriesofhypospadias
and forDNAobtained fromblood and saliva showed compa-
rable results in the subgroups (data not shown).
In Table 3 our results are compared with the results of
previously reported studies. We were unable to replicate
the results of Wang et al. and Thai et al. reporting an
FIG. 1. Flow chart of the selection of case samples for inclusion in the
current study. AGORA, Aetiologic Research into Genetic and
Occupational/Environmental Risk Factors for Anomalies in Children.
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association of rs523349 in SRD5A2 with hypospadias in
90 Chinese cases and 87 controls (24) and 158 Swedish,
Turkish, and Middle Eastern cases and 96 Swedish con-
trols (23), respectively. We did not replicate the associa-
tion of rs6932902 in ESR1 with hypospadias either, as
reported earlier by Watanabe et al. (25) in 43 Japanese
cases and 135 controls. These authors investigated eight
SNPs covering a linkage disequilibriumblock inESR1 and
found the strongest association with hypospadias for
rs6932902, which was nonsignificant in our sample, al-
though showing a trend in the same direction. Our find-
ings for rs2987983 in ESR2 and rs11119982 in ATF3
showed trends in theoppositedirection comparedwith the
earlier publications by Beleza-Meireles et al. (27), who
genotyped four haplotype-tagging SNPs in ESR2 in a
Swedish cohort of 348 cases and 377 controls and re-
ported a statistically significant association with hypos-
padias for rs2987983. They also genotyped 330 cases and
374 controls for eight haplotype-tagging SNPs in ATF3
and concluded that rs11119982was negatively associated
with hypospadias (29), whereas a positive associationwas
observed in our study.
Discussion
It is a well-known fact that most associations reported in
genetic studies do not replicate across subsequent studies
(35). This is true even for studies investigating very plau-
sible candidate genes for a phenotype or disorder, as is the
case in the current study, in which, among others, a gene
implicated inmonogenic forms of hypospadias (SRD5A2)
was investigated. To our knowledge, the current study
investigated the largest sample of hypospadias cases and
controls for associated SNPs thus far reported. We were
unable to replicate the results of three earlier studies in
Caucasianpopulations.As for the results of the twoearlier
studies in non-Caucasian populations, these findings did
not generalize to our Caucasian population. The lack of
consistency between our study and previously performed
studiesmight be caused by spurious results or chance find-
ings found in our or the earlier studies, especially in those
withvery small sample sizes, differences in the criteriaused
to select cases and/or controls, or a real difference between
the populations (36).
Population stratification, which occurs when cases and
controls are drawn from different subgroups that differ in
disease prevalence and frequency of the genetic variant,
may lead to spurious results. We selected only Caucasian
cases and controls living in the same area in The Nether-
lands to minimize the chance of population stratification.
Thai et al. (23) included cases from Sweden, Turkey, and
the Middle East, whereas all controls were Swedish, butTA
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when they restricted the analyses to only Swedish cases,
the association was still observed, making population
stratification in their study unlikely as well. We do not
expect spurious results due to the different sources of the
DNA used in our study because results were comparable
in the stratified analyses. Small sample sizes may result in
insufficient power to detect an association andmay lead to
genotype frequencies that are not representative of the
frequencies in the population from which the sample was
drawn due to chance. Therefore, we collected a large study
sample of approximately 600 cases and 600 controls, pro-
viding a power of 82–94%, given an alpha of 0.05, to detect
associations between hypospadias and SNPs with allele fre-
quencies between 0.1 and 0.5 and a dominant genetic effect
increasingtheriskofdisease1.5-fold(aconservativeestimate
based on the previous studies shown in Table 3).
Differences in results between our and other studies
may also be caused by disease heterogeneity due to differ-
ences in the criteria used to select the cases. Indeed, more
than 25% of the cases used in the Chinese and Japanese
studies hadmicropenis (24, 25), whichwere nearly absent
in our study population. Furthermore, the study by Thai
et al. (23) included a high proportion of familial cases.
However, a subanalysis in their publication restricted to
sporadic cases only still showed the association (23), sug-
gesting that familiality did not explain the observed asso-
ciation. All three studies mentioned above included more
hypospadias cases with a posterior localization of the me-
atus than we did (23–25). We tried to tackle this incon-
sistency between the studies by analyzing our data sepa-
rately for the different categories of hypospadias, but
comparable results were found in the different subgroups.
In addition, we excluded patients with disorders of sex
development or micropenis in an attempt to increase the
homogeneityofour sample.Thisdidnot change the results
either (data not shown). These findings suggest that lo-
calization of the meatus and familiality are no adequate
explanation for the differences in results.
Because the populations analyzed in the other studies
are indeed dissimilar to theDutch population and some of
the populations even differ in ethnicity, a real difference
between the populations studied might exist. There may
be a difference in the etiology of hypospadias, manifested
as other underlying trait loci or their alleles, or a difference
in environmental exposures between populations. One
can speculate that specific SNPs lead to an increased sus-
ceptibility of hypospadias only in the presence of an en-
vironmental exposure. Factors suspected to be of rele-
vance in the etiology of hypospadias and potentially
differing betweenpopulations includematernal age, assisted
reproductive techniques, and iron supplementation (5, 32,
37, 38). Furthermore, there might be a difference in genetic
backgrounds, affecting the associations if these are depen-
dent on interactions with other SNPs that are present in one
population but not in another or on linkage disequilibrium
with a causal allele. Because the SNPs in ESR1, ESR2, and
ATF3 are haplotype-tagging SNPs and haplotype block pat-
ternsmaydifferbetweenpopulations, theseSNPsmightbe in
linkage disequilibrium with the causal SNPs in some popu-
lations but not in others. The SNP in SRD5A2, which causes
a valine to leucine (V89L) substitution resulting in an ap-
proximately 30% decrease in enzyme activity (39, 40), is
likely to be a causal SNP but not in our population.
Our failure to replicate the previous findings in a large,
well-powered study should not be taken as evidence that
the tested genes do not contribute to disease risk. For the
reasons explained above, we cannot exclude the possibil-
ity that the SNPs investigated in this study are associated
TABLE 2. Association analyses for single nucleotide polymorphisms in SRD5A2, ESR1, ESR2 and ATF3 with
hypospadias
Controls 
n = 596 (%) 
Cases 
n = 620 (%) OR   (95% CI) 
χ2
P-value 
Controls  
n =1192 (%) 
Cases 
n =1240 (%) OR   (95% CI) 
χ2 
P-value 
Genotype frequencies Allele frequencies 
rs523349 in SRD5A2 
CC 290  (49%) 291  (48%) 1.00  (ref) ref 
CG 255  (43%) 263  (43%) 1.03  (0.81-1.30) 0.820 C   835  (70%)   845  (69%) 1.00  (ref) ref 
GG   51    (9%)   55    (9%) 1.07  (0.71-1.63) 0.733 G   357  (30%)   373  (31%) 1.03  (0.87-1.23) 0.719 
rs6932902 in ESR1 
GG 459  (77%) 448  (73%) 1.00  (ref) ref  
AG 128  (21%) 153  (25%) 1.22  (0.94-1.60) 0.139 G 1046  (88%) 1049  (85%) 1.00  (ref) ref 
AA     9    (2%)   16    (3%) 1.82  (0.80-4.16) 0.150 A   146  (12%)   185  (15%) 1.26  (1.00-1.60) 0.049 
rs2987983 in ESR2 
AA 265  (45%) 308  (50%) 1.00  (ref) ref  
AG 274  (46%) 249  (41%) 0.78  (0.62-0.99) 0.042 A   804  (67%)   865  (71%) 1.00  (ref) ref 
GG   56    (9%)   54    (9%) 0.83  (0.55-1.25) 0.370 G   386  (32%)   357  (29%) 0.86  (0.72-1.02) 0.087 
rs11119982 in ATF3 
CC 162  (27%) 132  (22%) 1.00  (ref) ref  
CT 285  (48%) 310  (51%) 1.33  (1.01-1.77) 0.043 C   609  (51%)   574  (47%) 1.00  (ref) ref 
TT 148  (25%) 170  (28%) 1.41  (1.03-1.94) 0.035 T   581  (49%)   650  (53%) 1.19  (1.01-1.39) 0.036 
The first shaded column presents the odds ratios and 95% confidence intervals comparing the two other genotypes to the most frequent
homozygous genotype in controls as well as the statistical significance of the differences in genotype distributions between cases and controls. The
second shaded column has the same structure, but for alleles.
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with hypospadias in some populations. In addition, one
should keep inmind thatwe examinedonly one SNPper gene.
Other SNPs, SNP-haplotypes, or other types of polymor-
phisms, such as variable number tandem repeats, e.g. those re-
ported in ESR2 (28) and potentially also copy number poly-
morphisms, may be of relevance for hypospadias risk as well.
Our study once again confirms the importance of rep-
lication studies for the validation of the results of genetic
association approaches. These studies can provide infor-
mation about the generalizability of the findings and con-
tribute to the determination of realistic estimates of effect
sizes. Inaddition, inthespecificcaseofhypospadias, inwhich
clear evidence regarding the molecular pathways leading to
disease is lacking,methods such as genome-wide association
studies may be called for rather than candidate gene ap-
proaches togeneratehypotheses regarding thepathwaysand
genes involved in the etiology of hypospadias.
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TABLE 3. Association analyses for single nucleotide polymorphisms in SRD5A2, ESR1, ESR2 and ATF3 with
hypospadias in our study and in previously published studies
   Controls   
    n     (%) 
   Cases 
    n    (%)   OR (95% CI) 
χ2
P-value 
    Controls   
      n   (%) 
     Cases 
      n   (%) OR (95% CI) 
χ2
P-value 
Genotype frequencies Allele frequencies 
rs523349 in SRD5A2 
Thai et al.(23) (mixed ethnicity) (n=158 cases, 96 controls) 
 CC   59  (62%)   44  (28%)   1.0  (ref) ref 
 CG   18  (19%)   64  (41%)   4.8  (2.5-9.2) <0.001 C   136  (71%)   152  (48%) 1.0  (ref) ref 
 GG   19  (20%)   50  (32%)   3.5  (1.8-6.8) <0.001 G     56  (29%)   164  (52%) 2.6  (1.8-3.8) <0.001 
Wang et al.(24) (Chinese) (n=90 cases, 87 controls) 
 CC   31  (36%)   16  (18%)   1.0  (ref) ref 
 CG   44  (51%)   52  (58%)   2.3  (1.1-4.7) 0.024 C   106  (61%)     84  (47%) 1.0  (ref) ref 
 GG   12  (14%)   22  (24%)   3.6  (1.4-9.0) 0.007 G     68  (39%)     96  (53%) 1.8  (1.2-2.7) 0.007 
Our results (n=609 cases, 596 controls)     
 CC 290  (49%) 291  (48%)   1.0  (ref) ref     
 CG 255  (43%) 263  (43%)   1.0  (0.8-1.3) 0.820 C   835  (70%)   845  (69%) 1.0  (ref) ref 
 GG   51    (9%)   55    (9%)   1.1  (0.7-1.6) 0.733 G   357  (30%)   373  (31%) 1.0  (0.9-1.2) 0.719 
rs6932902 in ESR1 
Watanabe et al. (25) (Japanese) (n=43 cases, 135 controls) 
 GG   80  (59%)   18  (42%)   1.0  (ref) ref 
 AG   51  (38%)   14  (33%)   1.2  (0.6-2.7) 0.619 G   211  (78%)     50  (58%) 1.0  (ref) ref 
 AA     4    (3%)   11  (26%) 12.2  (3.1-57.0)a <0.001 A     59  (22%)     36  (42%) 2.6  (1.5-4.3) <0.001 
Our results (n=617 cases, 596 controls) 
 GG 459  (77%) 448  (73%)   1.0  (ref) ref      
 AG 128  (22%) 153  (25%)   1.2  (0.9-1.6) 0.139 G 1046  (88%) 1049  (85%) 1.0  (ref) ref 
 AA     9    (2%)   16    (3%)   1.8  (0.8-4.2) 0.150 A   146  (12%)   185  (15%) 1.3  (1.0-1.6) 0.049 
rs2987983 in ESR2 
Beleza-Meireles et al. (27) (Swedish) (n=348 cases, 377 controls) 
 AA 182  (48%) 142  (41%)   1.0  (ref) ref 
 AG 162  (43%) 151  (43%)   1.2  (0.9-1.6) 0.264 A   526  (70%)   435  (63%) 1.0  (ref) ref 
 GG   33    (9%)   55  (16%)   2.1  (1.3-3.5) 0.002 G   228  (30%)   261  (38%) 1.4  (1.1-1.7) 0.004 
Our results (n=611 cases, 595 controls) 
 AA 265  (45%) 308  (50%)   1.0  (ref) ref      
 AG 274  (46%) 249  (41%)   0.8  (0.6-1.0) 0.042 A   804  (68%)   865  (71%) 1.0  (ref) ref 
 GG   56    (9%)   54    (9%)   0.8  (0.6-1.3) 0.370 G   386  (32%)   357  (29%) 0.9  (0.7-1.0) 0.087 
rs11119982 in ATF3 
Beleza-Meireles et al. (29) (Swedish) (n=330 cases, 374 controls) 
 CC   60  (16%)   82  (25%)   1.0  (ref) ref 
 CT 168  (45%) 160  (48%)   0.7  (0.5-1.0) 0.074 C   288  (39%)   324  (49%) 1.0  (ref) ref 
 TT 146  (39%)   88  (27%)   0.4  (0.3-0.7) <0.001 T   460  (61%)   336  (51%) 0.6  (0.5-0.8) <0.001 
Our results (n=612 cases, 595 controls) 
 CC 162  (27%) 132  (22%)   1.0  (ref) ref      
 CT 285   (48%) 310  (51%)   1.3  (1.0-1.8) 0.043 C   609  (51%)   574  (47) 1.0  (ref) ref 
 TT 148  (25%) 170  (28%)   1.4  (1.0-1.9) 0.035 T   581  (49%)   650  (53%) 1.2  (1.0-1.4) 0.036 
The left half of the table presents genotype data and the right half allelic data. For each SNP, both our results and those from previously published
studies are displayed. The first three columns of this table present the genotype distribution of the four SNPs investigated among hypospadias
cases and controls. The shaded column presents the odds ratios and 95% confidence intervals comparing the two other genotypes to the most
frequent homozygous genotype in controls as well as the statistical significance of the differences in genotype distributions between cases and
controls. The right half of the table has the same structure, but shows allele frequencies.
aExact 95% CI calculated using the Fisher exact method.
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